Artisan Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Artisan Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-132,116	Closed	-$4.12M	–	376
2025 Q4	$4.12M	Buy	+132,116	New	+$3.25M	0.01%	320
2020 Q3	–	Sell	-1,254,999	Closed	-$15.5M	–	348
2020 Q2	$15.5M	Sell	1,254,999 -1,678	-0.1%	-$19K	0.02%	277
2020 Q1	$11.3M	Buy	1,256,677 +64,572	+5%	+$662K	0.02%	262
2019 Q4	$11.7M	Buy	1,192,105 +38,037	+3%	+$340K	0.02%	274
2019 Q3	$7.94M	Buy	1,154,068 +115,309	+11%	+$883K	0.02%	265
2019 Q2	$9.59M	Buy	1,038,759 +416,805	+67%	+$5.03M	0.02%	257
2019 Q1	$9.75M	Buy	621,954 +241,219	+63%	+$4.25M	0.02%	247
2018 Q4	$5.87M	Buy	+380,735	New	+$7.81M	0.01%	249

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners's TEVA Position: Q1 2026 in Review

Artisan Partners sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 132,116 shares — an estimated $4.12M sold.

Artisan Partners first reported a position in TEVA in Q4 2018 and held it in 8 quarters. The position peaked at $15.5M in Q2 2020. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Artisan Partners reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Artisan Partners sold 132,116 Teva Pharmaceuticals shares in Q1 2026, an estimated $4.12M.
Artisan Partners first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 8 quarters.
Artisan Partners's Teva Pharmaceuticals position peaked at $15.5M in Q2 2020.
651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Artisan Partners's 13F filing for Q1 2026, filed 13 May 2026.